Cytokine profiles and CD8+T cells in the occurrence of acute and chronic hepatitis B

被引:2
|
作者
Xie, Si [1 ]
Yang, Liu [2 ]
Bi, Xiaoyue [2 ]
Deng, Wen [2 ]
Jiang, Tingting [2 ]
Lin, Yanjie [3 ]
Wang, Shiyu [2 ]
Zhang, Lu [2 ]
Liu, Ruyu [2 ]
Chang, Min [2 ]
Wu, Shuling [2 ]
Gao, Yuanjiao [2 ]
Hao, Hongxiao [2 ]
Shen, Ge [2 ]
Xu, Mengjiao [2 ]
Chen, Xiaoxue [2 ]
Hu, Leiping [2 ]
Lu, Yao [2 ]
Song, Rui [4 ]
Xie, Yao [2 ,3 ]
Li, Minghui [2 ,3 ]
机构
[1] Tsinghua Univ, Beijing Tsinghua Changgung Hosp, Div Hepatol, Sch Clin Med,Hepatopancreato Biliary Ctr, Beijing, Peoples R China
[2] Capital Med Univ, Beijing Ditan Hosp, Dept Hepatol, Div 2, Beijing, Peoples R China
[3] Peking Univ, Dept Hepatol, Ditan Teaching Hosp, Div 2, Beijing, Peoples R China
[4] Capital Med Univ, Beijing Ditan Hosp, Dept Infect Dis, Beijing, Peoples R China
来源
FRONTIERS IN IMMUNOLOGY | 2022年 / 13卷
关键词
chronic hepatitis B; acute hepatitis B; cytokines; CD8+T cells; immune tolerance; T-CELLS; VIRUS; HBV; HBEAG; RESPONSES; KINETICS; THERAPY; INNATE; IMPACT; LEVEL;
D O I
10.3389/fimmu.2022.1036612
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
ObjectiveWe explore the expression of functional molecules on CD8+ T lymphocytes, cytokines concentration, and their correlation to occurrence of hepatitis B and hepatitis B virus (HBV) desoxyribose nucleic acid (DNA), hepatitis B surface antigen (HBsAg), hepatitis B envelope antigen (HBeAg), and alanine aminotransferase (ALT) in patients infected with HBV. MethodsThis is a single center study. 32 patients with acute hepatitis B (AHB), 30 patients with immune tolerant (IT) phase chronic HBV infected, and 50 patients with chronic hepatitis B (CHB) were enrolled. The activation molecules (CD69) and the apoptosis-inducing molecules (CD178) on surface of CD8+ T lymphocytes were tested by the flow cytometry. Fms-like tyrosine kinase 3 ligand (Flt-3L), interleukin 17A (IL-17A), interferon gamma (IFN-gamma), and Interferon alpha 2 (IFN-alpha 2) were quantitated by Luminex assay. We use linear regression analysis to analyze their correlations to ALT, HBV DNA, HBsAg, and HBeAg. ResultsThe frequency of CD69+CD8+ T lymphocytes in CHB and AHB groups were increased significantly compared with IT group (4.19[3.01, 6.18]% and 4.45[2.93, 6.71]% vs. 3.02[2.17, 3.44]%; H=26.207, P=0.001; H=28.585, P=0.002), and the mean fluorescence intensity (MFI) of CD69 in AHB group was significantly higher than IT and CHB groups (27.35[24.88, 32.25] vs. 20.45[19.05, 27.75] and 23.40[16.78, 28.13]; H=25.832, P=0.005 and H=22.056, P=0.008). In IT group, HBsAg levels and HBV DNA loads were negatively correlated with CD69MFI (beta=-0.025, t=-2.613, P=0.014; beta=-0.021, t=-2.286, P=0.030), meanwhile, HBeAg was negatively related to the frequency of CD69+CD8+ T lymphocytes (beta=-61.306, t=-2.116, P=0.043). In AHB group, IFN-alpha 2 was positively related to the frequency of CD8+ T lymphocytes (beta=6.798, t=2.629, P=0.016); however, in CHB group, IFN-alpha 2 was negatively associated with frequency of CD8+ T lymphocytes (beta=-14.534, t=-2.085, P=0.043). In CHB group, HBeAg was positively associated with frequency of CD69+CD8+ T lymphocytes (beta=43.912, t=2.027, P=0.048). In AHB group, ALT was positively related to CD69MFI (beta=35.042, t=2.896, P=0.007), but HBsAg was negatively related to CD178MFI (beta=-0.137, t=-3.273, P=0.003). ConclusionsThe activation of CD8+ T lymphocytes was associated with the occurrence of AHB and CHB. However, due to the insufficient expression of functional molecules of CD8+ T lymphocytes and the depletion of CD8+ T lymphocytes, CHB patients were difficult to recover from HBV infection.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] T-bet expression in CD8+T cells associated with chronic hepatitis B virus infection
    Fan, Rongshan
    Lan, Yinghua
    Chen, Jiwang
    Huang, Yanxin
    Yan, Qin
    Jiang, Lisheng
    Song, Shupeng
    Li, Yongguo
    VIROLOGY JOURNAL, 2016, 13
  • [2] MicroRNA Expression Patterns of CD8+T Cells in Acute and Chronic Brucellosis
    Budak, Ferah
    Bal, S. Haldun
    Tezcan, Gulcin
    Guvenc, Furkan
    Akalin, E. Halis
    Goral, Guher
    Deniz, Gunnur
    Oral, H. Barbaros
    PLOS ONE, 2016, 11 (11):
  • [3] KLRG1-expressing CD8+T cells are exhausted and polyfunctional in patients with chronic hepatitis B
    Wang, Li
    Liao, Fangli
    Yang, Liping
    Jiang, Linshan
    Duan, Liang
    Wang, Bo
    Mu, Di
    Chen, Juan
    Huang, Ying
    Hu, Qin
    Chen, Weixian
    PLOS ONE, 2024, 19 (05):
  • [4] Interleukin 12 mediated recovery of effector cytokine production in hepatitis B virus-specific CD8+T cells
    Schurich, A.
    Pallett, L.
    Lubowiecki, M.
    Singh, H.
    Rosenberg, W.
    Maini, M.
    IMMUNOLOGY, 2011, 135 : 58 - 58
  • [5] THE BREADTH OF CD8+T CELL RESPONSES IN CHRONIC AND RESOLVED HEPATITIS B VIRUS INFECTION
    Ehrenmann, P.
    Kiraithe, M.
    Lang, J.
    Jacobi, F.
    Thimme, R.
    Neumann-Haefelin, C.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S520 - S521
  • [6] CYTOKINE PRODUCTION BY HIGHLY PURIFIED HUMAN CD8+T CELLS
    LI, Y
    RICHARDS, D
    NOBEL, A
    KEMENY, DM
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1995, 107 (1-3) : 354 - 355
  • [7] Effects of Chronic Hepatitis B Virus (HBV) Antigen Exposure on the Epitope-Specificity of CD8+T Cells
    Hasanpourghadi, Mohadeseh
    Luber, Andrew
    Magowan, Colin
    Zhou, Xiang
    Ertl, Hildegund
    MOLECULAR THERAPY, 2020, 28 (04) : 524 - 524
  • [8] Themis regulates cytokine signals in mature CD8+T cells
    Brzostek, J.
    Zhao, X.
    Mehta, M.
    Gascoigne, N.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2016, 46 : 22 - 22
  • [9] Different cytokine profiles of intrahepatic T cells in chronic hepatitis B and hepatitis C virus infections
    Bertoletti, A
    DElios, MM
    Boni, C
    DeCarli, M
    Zignego, AL
    Durazzo, M
    Missale, G
    Penna, A
    Fiaccadori, F
    DelPrete, G
    Ferrari, C
    GASTROENTEROLOGY, 1997, 112 (01) : 193 - 199
  • [10] Interleukin-37 suppresses the cytotoxicity of hepatitis B virus peptides-induced CD8+T cells in patients with acute hepatitis B
    Liu, Qian
    Zhou, Qiang
    Wang, Mingrui
    Pang, Bo
    BIOMOLECULES AND BIOMEDICINE, 2023, 23 (03): : 527 - 534